[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Girault et al., 1989 - Google Patents

Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy.

Girault et al., 1989

View PDF
Document ID
3816937098409033363
Author
Girault J
Raisman-Vozari R
Agid Y
Greengard P
Publication year
Publication venue
Proceedings of the National Academy of Sciences

External Links

Snippet

This study was undertaken to evaluate the levels of cAMP-regulated phosphoproteins in the striatum of patients with neurodegenerative diseases of the dopaminergic system. Postmortem samples of caudate nucleus and putamen from 24 control subjects, 23 patients …
Continue reading at www.pnas.org (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
Girault et al. Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy.
Yase The pathogenesis of amyotrophic lateral sclerosis
US4699875A (en) Diagnosis of amyotrophic lateral sclerosis by neurotrophic factors
Okamura et al. Sodium bicarbonate in seminal plasma stimulates the motility of mammalian spermatozoa through direct activation of adenylate cyclase.
Nemeroff et al. Regional brain concentrations of neuropeptides in Huntington's chorea and schizophrenia
Mann et al. The noradrenergic system in Alzheimer and multi-infarct dementias.
Schultz et al. Endogenous amino acid pool sizes in mouse eggs and preimplantation embryos
Geffen et al. Plasma dopamine β-hydroxylase and noradrenaline amounts in essential hypertension
Neufeld et al. In vitro determination of the ability of drugs to bind to adrenergic receptors.
McLachlan et al. Calmodulin and calbindin D28K in Alzheimer disease
Chase et al. Effect of Excess Phenylalanine and of Other Amino Acids on Brain Developmen in the Infant Rat
US4701407A (en) Diagnosis of Alzheimer disease
Humphrey et al. Observations on the presence of plasma proteins in skin and tendon
DE68924354T2 (en) METHOD AND COMPOSITIONS FOR EARLY DETECTING TREATMENT OF INSULIN-DEPENDENT DIABETES MELLITUS (IDDM).
Orci et al. Morphological and biochemical studies of B cells of fetal rat endocrine pancreas in organ culture: evidence for (pro) insulin biosynthesis
Strickler et al. Adenosine 3′, 5′-monophosphate in reproducing and differentiated trypanosomes
Brooks et al. EFFECTS OF DIET AND ACUTE NORADRENALINE TREATMENT ON BROWN ADIPOSE TISSUE DEVELOPMENT AND MITOCHONDRIAL PURINE‐NUCLEOTIDE BINDING
Mitsuma et al. Concentrations of immunoreactive thyrotropin-releasing hormone in spinal cord of patients with amyotrophic lateral sclerosis
Mariotti et al. Comparison of radioassay and haemagglutination methods for anti-thyroid microsomal antibodies.
US6458549B2 (en) Methods of diagnosing renal salt wasting syndrome and Alzheimer's disease and methods of treating the same
Ashby et al. Alteration of 5-HT uptake by plasma fractions in the premenstrual syndrome
HEDBERG et al. Six cases of hypertensive crisis in patients on tranylcypromine after eating chicken livers
US5017375A (en) Method to prepare a neurotrophic composition
Le Fur et al. [3H] spiroperidol binding on lymphocytes: changes in two different groups of schizophrenic patients and effect of neuroleptic treatment
Buhlmann Haemolymph vitellogenin, juvenile hormone, and ooÈcyte growth in the adult cockroach Nauphoeta cinerea during first pre-oviposition period